DK135991D0 - 1h-imidazooe4,5-caaquinolin-5-oxyforbindelse - Google Patents

1h-imidazooe4,5-caaquinolin-5-oxyforbindelse

Info

Publication number
DK135991D0
DK135991D0 DK911359A DK135991A DK135991D0 DK 135991 D0 DK135991 D0 DK 135991D0 DK 911359 A DK911359 A DK 911359A DK 135991 A DK135991 A DK 135991A DK 135991 D0 DK135991 D0 DK 135991D0
Authority
DK
Denmark
Prior art keywords
carbon atoms
imidazooe4
caaquinolin
group
oxy compound
Prior art date
Application number
DK911359A
Other languages
English (en)
Other versions
DK165921B (da
DK135991A (da
DK165921C (da
Inventor
John F Gerster
Original Assignee
Riker Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riker Laboratories Inc filed Critical Riker Laboratories Inc
Publication of DK135991A publication Critical patent/DK135991A/da
Publication of DK135991D0 publication Critical patent/DK135991D0/da
Publication of DK165921B publication Critical patent/DK165921B/da
Application granted granted Critical
Publication of DK165921C publication Critical patent/DK165921C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Physical Water Treatments (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Quinoline Compounds (AREA)
  • Alarm Systems (AREA)
  • Luminescent Compositions (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Lubricants (AREA)
DK135991A 1983-11-18 1991-07-16 1h-imidazooe4,5-caaquinolin-5-oxyforbindelser DK165921C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US55315783A 1983-11-18 1983-11-18
US55315883A 1983-11-18 1983-11-18
US55315783 1983-11-18
US55315883 1983-11-18

Publications (4)

Publication Number Publication Date
DK135991A DK135991A (da) 1991-07-16
DK135991D0 true DK135991D0 (da) 1991-07-16
DK165921B DK165921B (da) 1993-02-08
DK165921C DK165921C (da) 1993-06-28

Family

ID=27070262

Family Applications (6)

Application Number Title Priority Date Filing Date
DK542684A DK164280C (da) 1983-11-18 1984-11-15 1h-imidazooe4,5-caaquinolin eller derivat deraf og farmaceutisk praeparat indeholdende en saadan forbindelse
DK136191A DK164452C (da) 1983-11-18 1991-07-16 3-nitroquinolinderivat
DK136091A DK164451C (da) 1983-11-18 1991-07-16 3-aminoquinolinderivat
DK135791A DK169179B1 (da) 1983-11-18 1991-07-16 1H-imidazo[4,5-c]quinolin-4-amin, farmaceutisk præparat indeholdende en sådan forbindelse og fremga ngsmåde til fremstilling af en sådan forbindelse
DK135991A DK165921C (da) 1983-11-18 1991-07-16 1h-imidazooe4,5-caaquinolin-5-oxyforbindelser
DK135891A DK164455C (da) 1983-11-18 1991-07-16 1h-imidazooe4,5-caaquinolin-4-chlorforbindelser

Family Applications Before (4)

Application Number Title Priority Date Filing Date
DK542684A DK164280C (da) 1983-11-18 1984-11-15 1h-imidazooe4,5-caaquinolin eller derivat deraf og farmaceutisk praeparat indeholdende en saadan forbindelse
DK136191A DK164452C (da) 1983-11-18 1991-07-16 3-nitroquinolinderivat
DK136091A DK164451C (da) 1983-11-18 1991-07-16 3-aminoquinolinderivat
DK135791A DK169179B1 (da) 1983-11-18 1991-07-16 1H-imidazo[4,5-c]quinolin-4-amin, farmaceutisk præparat indeholdende en sådan forbindelse og fremga ngsmåde til fremstilling af en sådan forbindelse

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK135891A DK164455C (da) 1983-11-18 1991-07-16 1h-imidazooe4,5-caaquinolin-4-chlorforbindelser

Country Status (15)

Country Link
EP (2) EP0145340B1 (da)
JP (1) JPS60123488A (da)
KR (1) KR900005657B1 (da)
AT (2) ATE84525T1 (da)
AU (2) AU581190B2 (da)
CA (1) CA1271477A (da)
DE (3) DE19975027I2 (da)
DK (6) DK164280C (da)
ES (1) ES537677A0 (da)
IE (1) IE57874B1 (da)
IL (2) IL84537A (da)
NL (2) NL980043I1 (da)
NO (7) NO163819C (da)
NZ (1) NZ210228A (da)
PH (1) PH22338A (da)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1306260C (en) * 1985-10-18 1992-08-11 Shionogi & Co., Ltd. Condensed imidazopyridine derivatives
US4942168A (en) * 1987-07-13 1990-07-17 Hoechst-Roussel Pharmaceuticals Inc. Hydroxyquinoline amines, and method of enhancing memory in mammals
CA1335996C (en) * 1988-02-16 1995-06-20 Susumu Takada 2-substituted carbonylimidazo¬4,5-c|quinolines
EP0361489A3 (en) * 1988-09-30 1991-06-12 Chugai Seiyaku Kabushiki Kaisha Novel 3,4-diaminoquinoline and pyridine compounds
ES2094141T3 (es) * 1989-02-27 1997-01-16 Riker Laboratories Inc 1h-imidazo(4,5-c)quinolin-4-aminas como antivirales.
US4994468A (en) * 1989-03-07 1991-02-19 Kyowa Hakko Kogyo Co., Ltd. Imidazoquinolone derivatives
US4929624A (en) * 1989-03-23 1990-05-29 Minnesota Mining And Manufacturing Company Olefinic 1H-imidazo(4,5-c)quinolin-4-amines
CA2021338C (en) * 1989-07-18 1996-07-16 Fumio Suzuki Imidazoquinolone derivatives
US4988815A (en) * 1989-10-26 1991-01-29 Riker Laboratories, Inc. 3-Amino or 3-nitro quinoline compounds which are intermediates in preparing 1H-imidazo[4,5-c]quinolines
FR2654021B1 (fr) * 1989-11-07 1992-02-28 Simond Jacques Procede de vitrification de cendres volantes et dispositif pour sa mise en óoeuvre.
GB8928281D0 (en) * 1989-12-14 1990-02-21 Smith Kline French Lab Compounds
CA2043715C (en) * 1990-06-01 1997-01-07 Fumio Suzuki Imidazonaphthyridine derivatives
CZ285050B6 (cs) * 1991-03-01 1999-05-12 Minnesota Mining And Manufacturing Company 1-Substituované, 2-substituované-1H-imidazo/4,5-c /chinolin-4-aminy
US5266575A (en) * 1991-11-06 1993-11-30 Minnesota Mining And Manufacturing Company 2-ethyl 1H-imidazo[4,5-ciquinolin-4-amines
IL105325A (en) * 1992-04-16 1996-11-14 Minnesota Mining & Mfg Immunogen/vaccine adjuvant composition
US5395937A (en) * 1993-01-29 1995-03-07 Minnesota Mining And Manufacturing Company Process for preparing quinoline amines
US5693811A (en) * 1996-06-21 1997-12-02 Minnesota Mining And Manufacturing Company Process for preparing tetrahdroimidazoquinolinamines
JP4101302B2 (ja) * 1997-01-09 2008-06-18 テルモ株式会社 新規アミド誘導体および合成中間体
JPH10298181A (ja) * 1997-04-25 1998-11-10 Sumitomo Pharmaceut Co Ltd タイプ２ヘルパーｔ細胞選択的免疫応答抑制剤
JP2000119271A (ja) 1998-08-12 2000-04-25 Hokuriku Seiyaku Co Ltd １ｈ―イミダゾピリジン誘導体
US7253199B2 (en) * 2001-10-23 2007-08-07 Applied Research Systems Ars Holding N.V. Azole derivatives and pharmaceutical compositions containing them
GB0211649D0 (en) 2002-05-21 2002-07-03 Novartis Ag Organic compounds
ATE338044T1 (de) 2002-07-23 2006-09-15 Teva Gyogyszergyar Zartkoeruen Herstellung von 1h-imidazoc4,5-c)chinolin-4- aminen ber 1h-imidazoc4,5-c)chinolin-4- phthalimidzwischenprodukte
AU2003254221A1 (en) 2002-07-26 2004-02-16 Biogal Gyogyszergyar Rt. Preparation of 1h-imidazo (4,5-c) quinolin-4-amines via novel 1h-imidazo (4,5-c) quinolin-4-cyano and 1h-imidazo (4,5-c) quinolin-4-carboxamide intermediates
JP2007502293A (ja) 2003-08-12 2007-02-08 スリーエム イノベイティブ プロパティズ カンパニー ヒドロキシルアミン置換イミダゾ含有化合物
RU2006105101A (ru) * 2003-08-27 2007-10-10 3М Инновейтив Пропертиз Компани (US) Арилокси и арилалкиленокси замещенные имидазохинолины
CA2537763A1 (en) 2003-09-05 2005-03-17 3M Innovative Properties Company Treatment for cd5+ b cell lymphoma
US7687628B2 (en) 2003-10-01 2010-03-30 Taro Pharmaceuticals U.S.A., Inc. Method of preparing 4-amino-1H-imidazo(4,5-c)quinolines and acid addition salts thereof
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
AU2004278014B2 (en) 2003-10-03 2011-04-28 3M Innovative Properties Company Alkoxy substituted imidazoquinolines
ITMI20032121A1 (it) * 2003-11-04 2005-05-05 Dinamite Dipharma Spa In Forma Abbr Eviata Dipharm Procedimento per la preparazione di imiquimod e suoi intermedi
JP2007511527A (ja) 2003-11-14 2007-05-10 スリーエム イノベイティブ プロパティズ カンパニー オキシム置換イミダゾ環化合物
US8598192B2 (en) 2003-11-14 2013-12-03 3M Innovative Properties Company Hydroxylamine substituted imidazoquinolines
WO2005051317A2 (en) 2003-11-25 2005-06-09 3M Innovative Properties Company Substituted imidazo ring systems and methods
WO2005066170A1 (en) 2003-12-29 2005-07-21 3M Innovative Properties Company Arylalkenyl and arylalkynyl substituted imidazoquinolines
CA2551399A1 (en) 2003-12-30 2005-07-21 3M Innovative Properties Company Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides
US8697873B2 (en) 2004-03-24 2014-04-15 3M Innovative Properties Company Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
US8017779B2 (en) 2004-06-15 2011-09-13 3M Innovative Properties Company Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
US7915281B2 (en) 2004-06-18 2011-03-29 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method
US7897609B2 (en) 2004-06-18 2011-03-01 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
US8026366B2 (en) 2004-06-18 2011-09-27 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
JP5313502B2 (ja) 2004-12-30 2013-10-09 スリーエム イノベイティブ プロパティズ カンパニー 置換キラル縮合［１，２］イミダゾ［４，５−ｃ］環状化合物
JP5543068B2 (ja) 2004-12-30 2014-07-09 スリーエム イノベイティブ プロパティズ カンパニー キラル縮合［１，２］イミダゾ［４，５−ｃ］環状化合物
JP2008530022A (ja) 2005-02-04 2008-08-07 コーリー ファーマシューティカル グループ，インコーポレイテッド 免疫反応調節物質を含む水性ゲル処方物
AU2006213746A1 (en) 2005-02-11 2006-08-17 Coley Pharmaceutical Group, Inc. Oxime and hydroxylamine substituted imidazo(4,5-c) ring compounds and methods
WO2006107853A2 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. Pyrazolopyridine-1,4-diamines and analogs thereof
AU2006232375A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
ES2577514T3 (es) 2005-08-22 2016-07-15 The Regents Of The University Of California Antagonistas de TLR
EP2029597A4 (en) 2006-05-31 2011-11-23 Univ California purine analogs
WO2008008432A2 (en) 2006-07-12 2008-01-17 Coley Pharmaceutical Group, Inc. Substituted chiral fused( 1,2) imidazo (4,5-c) ring compounds and methods
PL2510946T3 (pl) 2007-02-07 2015-12-31 Univ California Koniugaty syntetycznych agonistów tlr i ich zastosowania
EP2009002A1 (en) * 2007-06-21 2008-12-31 Institut National De La Sante Et De La Recherche Medicale (Inserm) New process for the manufacture of 1H-imidazo [4,5-c]-quinoline ring systems
WO2010088924A1 (en) 2009-02-06 2010-08-12 Telormedix Sa Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
US8729088B2 (en) 2009-02-11 2014-05-20 The Regents Of The University Of California Toll-like receptor modulators and treatment of diseases
ES2617451T3 (es) * 2010-08-17 2017-06-19 3M Innovative Properties Company Composiciones lipidadas de compuestos modificadores de la respuesta inmunitaria, formulaciones, y métodos
US8728486B2 (en) 2011-05-18 2014-05-20 University Of Kansas Toll-like receptor-7 and -8 modulatory 1H imidazoquinoline derived compounds
IN2014KN00948A (da) 2011-10-04 2015-08-21 Janus Biotherapeutics Inc
KR20210007046A (ko) * 2013-02-01 2021-01-19 웰스태트 테러퓨틱스 코포레이션 항염증, 항진균, 항기생충, 및 항암 활성을 갖는 아민 화합물
AU2014230017A1 (en) 2013-03-15 2015-09-17 Syngenta Participations Ag Microbicidally active imidazopyridine derivatives
ES2538880B1 (es) * 2013-12-24 2016-09-08 Laboratorios Viñas S.A. Un procedimiento para obtener 4-amino-1-isobutil-1H-imidazo[4,5-c]quinoleína
ES2916873T3 (es) 2014-01-10 2022-07-06 Birdie Biopharmaceuticals Inc Compuestos y composiciones para inmunoterapia
JP6760919B2 (ja) 2014-07-09 2020-09-23 バーディー バイオファーマシューティカルズ インコーポレイテッド 腫瘍を治療するための抗ｐｄ−ｌ１組み合わせ
MX2018003215A (es) * 2015-09-14 2018-06-08 Pfizer Derivados de imidazo[4,5-c]quinolina e imidazo[4,5-c][1,5]naftirid ina novedosos como inhibidores de lrrk2.
CN115252792A (zh) 2016-01-07 2022-11-01 博笛生物科技有限公司 用于治疗肿瘤的抗-egfr组合
CN115554406A (zh) 2016-01-07 2023-01-03 博笛生物科技有限公司 用于治疗肿瘤的抗-cd20组合
US10533007B2 (en) 2016-04-19 2020-01-14 Innate Tumor Immunity, Inc. NLRP3 modulators
US10556903B2 (en) 2016-04-19 2020-02-11 Innate Tumor Immunity, Inc. NLRP3 modulators
US11697851B2 (en) 2016-05-24 2023-07-11 The Regents Of The University Of California Early ovarian cancer detection diagnostic test based on mRNA isoforms
TWI674261B (zh) 2017-02-17 2019-10-11 美商英能腫瘤免疫股份有限公司 Nlrp3 調節劑
CN108794467A (zh) 2017-04-27 2018-11-13 博笛生物科技有限公司 2-氨基-喹啉衍生物
WO2018232725A1 (en) 2017-06-23 2018-12-27 Birdie Biopharmaceuticals, Inc. PHARMACEUTICAL COMPOSITIONS
FR3113287B1 (fr) 2020-08-07 2023-06-23 Phv Pharma Procédé industriel de synthèse de l’imiquimod à partir de la quinolèine-2,4-diol applicable à son utilisation pharmaceutique

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3700674A (en) * 1969-04-30 1972-10-24 American Cyanamid Co 4-alkylamino-3-nitroquinolines
RO86850B (ro) * 1982-05-03 1985-05-31 Eli Lilly And Company Procedeu pentru prepararea unor 2-fenilimidazo [4,5 c] piridine

Also Published As

Publication number Publication date
CA1271477A (en) 1990-07-10
IL84537A0 (en) 1988-04-29
NL980043I1 (nl) 1999-02-01
DK165921B (da) 1993-02-08
DK135891A (da) 1991-07-16
NO165146C (no) 1991-01-02
EP0145340A2 (en) 1985-06-19
NO1999015I1 (no) 1999-07-08
ATE84525T1 (de) 1993-01-15
JPS60123488A (ja) 1985-07-02
KR900005657B1 (ko) 1990-08-03
NO844565L (no) 1985-05-20
AU3540284A (en) 1985-05-23
DK542684A (da) 1985-05-19
NL980041I2 (nl) 1999-07-01
DK169179B1 (da) 1994-09-05
NO165147C (no) 1991-01-02
ES8603477A1 (es) 1985-12-16
DK164451C (da) 1992-11-09
DK136191D0 (da) 1991-07-16
AU581190B2 (en) 1989-02-16
ES537677A0 (es) 1985-12-16
IE842952L (en) 1985-05-18
DK136091A (da) 1991-07-16
DE19975027I2 (de) 2000-09-21
NO890823D0 (no) 1989-02-27
DK135991A (da) 1991-07-16
IL84537A (en) 1990-12-23
KR850003890A (ko) 1985-06-29
NO163819C (no) 1990-08-01
JPH0586391B2 (da) 1993-12-10
DE3486043T2 (de) 1993-06-03
EP0310950B1 (en) 1993-01-13
NO168705B (no) 1991-12-16
DK164451B (da) 1992-06-29
NO163819B (no) 1990-04-17
DK542684D0 (da) 1984-11-15
NO169437B (no) 1992-03-16
DK164455B (da) 1992-06-29
DK164452C (da) 1992-11-09
DK136191A (da) 1991-07-16
DK164280B (da) 1992-06-01
NO165145C (no) 1991-01-02
NO890824D0 (no) 1989-02-27
DK165921C (da) 1993-06-28
DE3481124D1 (de) 1990-03-01
DK135891D0 (da) 1991-07-16
DE3486043D1 (de) 1993-02-25
DK135791D0 (da) 1991-07-16
PH22338A (en) 1988-08-12
EP0145340A3 (en) 1986-06-11
DK164452B (da) 1992-06-29
NO890823L (no) 1985-05-20
NO165145B (no) 1990-09-24
NL980041I1 (nl) 1999-02-01
NO890824L (no) 1985-05-20
EP0145340B1 (en) 1990-01-24
IE57874B1 (en) 1993-05-05
NO890826D0 (no) 1989-02-27
NO165146B (no) 1990-09-24
EP0310950A1 (en) 1989-04-12
NO890825L (no) 1985-05-20
NO169437C (no) 1992-06-24
DK164455C (da) 1992-11-16
NO890825D0 (no) 1989-02-27
DK164280C (da) 1992-11-30
DK136091D0 (da) 1991-07-16
NO890822D0 (no) 1989-02-27
AU611997B2 (en) 1991-06-27
NO165147B (no) 1990-09-24
NZ210228A (en) 1989-01-27
NO890822L (no) 1985-05-20
NO890826L (no) 1985-05-20
DK135791A (da) 1991-07-16
ATE49763T1 (de) 1990-02-15
NO168705C (no) 1992-03-25
AU2991189A (en) 1989-06-15

Similar Documents

Publication Publication Date Title
DK135891D0 (da) 1h-imidazooe4,5-caaquinolin-4-chlorforbindelse

Legal Events

Date Code Title Description
PUP Patent expired